These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8346930

  • 1. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
    Hirashima Y, Shimura T, Tanaka Y, Demukai H, Kubota T, Kobayashi T, Suzuki A.
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
    [Abstract] [Full Text] [Related]

  • 2. [Chemotherapy in malignant gynecologic tumors using intraperitoneal catheter with a subcutaneous reservoir].
    Shimizu A, Kimura T, Funatsu M, Hada Y, Araki H, Notake Y.
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1795-9. PubMed ID: 1877820
    [Abstract] [Full Text] [Related]

  • 3. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
    Shimizu A, Kimura T, Funatsu M, Hada Y, Tamura K, Taguchi A, Miyakawa Z, Notake Y.
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345
    [Abstract] [Full Text] [Related]

  • 4. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Royer B, Delroeux D, Guardiola E, Combe M, Hoizey G, Montange D, Kantelip JP, Chauffert B, Heyd B, Pivot X.
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
    [Abstract] [Full Text] [Related]

  • 5. [Significance and effects of intraperitoneal cisplatin administration for ovarian cancer].
    Shimizu A, Ookubo K, Hasegawa J, Endoh T, Fujiwara O, Yoda A, Okuyama D, Narabayashi A, Kimura T, Takahashi J, Notake Y.
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1801-5. PubMed ID: 10560398
    [Abstract] [Full Text] [Related]

  • 6. [The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients].
    Fujiwara K, Yamauchi H, Sawada S, Koike H, Mohri H, Ohishi Y, Kohno I.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2373-9. PubMed ID: 1463344
    [Abstract] [Full Text] [Related]

  • 7. [An aged patient with stage IV ovarian cancer successfully treated by intraperitoneal consecutive administration of cisplatin].
    Narimatsu A, Okada O.
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1225-9. PubMed ID: 9679588
    [Abstract] [Full Text] [Related]

  • 8. [The value of a Tenckhoff catheter in ovarian cancer].
    Kato N, Arakawa A, Yasui Y, Suzumori K, Suzumori K, Yagami Y.
    Gan To Kagaku Ryoho; 1991 May; 18(6):1025-30. PubMed ID: 2029187
    [Abstract] [Full Text] [Related]

  • 9. [Intraperitoneal (i.p.) chemotherapy in the management of ovarian cancer--pharmacokinetics and methods of sequential i.p. chemotherapy].
    Noda T, Adachi S, Yamamoto T, Hirooka C, Kiyozuka Y, Adachi S, Oku M, Ichijo M.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1561-8. PubMed ID: 2389949
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacokinetics of carboplatin after intraperitoneal administration and clinical effect in ovarian cancer].
    Ohno M, Hirokawa M, Hando T.
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2355-61. PubMed ID: 1463342
    [Abstract] [Full Text] [Related]

  • 11. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T, Klasa-Mazurkiewicz D, Emerich J, Kobierski J.
    Acta Obstet Gynecol Scand; 2009 Dec; 88(4):463-7. PubMed ID: 19235559
    [Abstract] [Full Text] [Related]

  • 12. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
    Noda T, Oku M, Kiyozuka Y, Ninomiya Y, Hino K, Okamura Y, Maruyama M, Ichijo M.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
    [Abstract] [Full Text] [Related]

  • 13. [The effect of intraperitoneal and intra-aortic chemotherapy for unresectable gastric cancer].
    Kawasaki S, Nagai K, Maruyama S, Murakami M, Yoshizane K, Morokoshi Y, Kawai K, Yamamoto M, Soda M.
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2256-9. PubMed ID: 7944453
    [Abstract] [Full Text] [Related]

  • 14. [A case report: ovarian carcinoma IVth can become complete remission by immunochemotherapy].
    Shimizu A, Hondoh T, Watanabe S, Moriyama S, Yoshida K, Miyakawa Z, Kimura T, Notake Y, Mitsuya T.
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2346-9. PubMed ID: 7944476
    [Abstract] [Full Text] [Related]

  • 15. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
    Berry E, Matthews KS, Singh DK, Buttin BM, Lurain JR, Alvarez RD, Schink J.
    Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
    [Abstract] [Full Text] [Related]

  • 16. [Intraperitoneal chemotherapy of metastatic ovarian cancer].
    Hasegawa E, Watanabe H, Ohmura G, Hirakawa S, Momose K.
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1742-4. PubMed ID: 1530346
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C, Huang R, Lian L.
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [Abstract] [Full Text] [Related]

  • 18. Intraperitoneal versus intravenous cisplatin in combination with intravenous cyclophosphamide and epidoxorubicin in optimally cytoreduced advanced epithelial ovarian cancer: a randomized trial of the Gruppo Oncologico Nord-Ovest.
    Gadducci A, Carnino F, Chiara S, Brunetti I, Tanganelli L, Romanini A, Bruzzone M, Conte PF.
    Gynecol Oncol; 2000 Feb; 76(2):157-62. PubMed ID: 10637064
    [Abstract] [Full Text] [Related]

  • 19. A phase II study of intraperitoneal cisplatin and thiotepa in residual ovarian carcinoma: a Gynecologic Oncology Group study.
    Feun LG, Blessing JA, Major FJ, DiSaia PJ, Alvarez RD, Berek JS.
    Gynecol Oncol; 1998 Dec; 71(3):410-5. PubMed ID: 9887240
    [Abstract] [Full Text] [Related]

  • 20. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look.
    Makhija S, Sabbatini P, Aghajanian C, Venkatraman E, Spriggs DR, Barakat R.
    Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.